Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (GMRE), a Maryland corporation, with a report date of June 23, 2025, covering events occurring on June 20, 2025. The filing details a significant leadership transition involving the departure of the Chief Executive Officer and the appointment of a successor.
Key Financial Metrics
This filing is a current report regarding corporate governance and executive compensation; it does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes
- Executive Departure: Jeffrey M. Busch was removed from his positions as Chief Executive Officer and President, effective June 23, 2025, pursuant to a Transition and Separation Agreement. He will continue to serve as non-executive Chairman of the Board.
- Executive Appointment: Mark O. Decker, Jr. was appointed Chief Executive Officer, President, and Director, effective June 23, 2025.
- Board Expansion: The Board of Directors increased its size from seven to eight members to accommodate Mr. Decker's appointment.
Guidance, Outlook, and Compensation Arrangements
The filing outlines the terms of Mr. Decker's Employment Agreement, effective June 23, 2025:
- Term: Initial three-year term with automatic one-year renewals unless 90 days' notice of non-renewal is provided.
- Base Salary: $700,000 annually.
- Bonus Structure: Target annual cash bonus of at least 100% of Base Salary (payable in cash and LTIP Units) beginning in 2026. A prorated bonus applies for 2025.
- Equity Awards:
- Initial LTIP Award: One-time grant valued at $1,000,000, vesting in full on the third anniversary.
- 2026 LTIP Award: Target aggregate value of $1,200,000.
- Relocation: $75,000 cash payment for relocation to the Washington, D.C. area.
- Severance: In the event of a "Qualifying Termination" (without cause or for good reason), Mr. Decker is entitled to two times the sum of Base Salary and Target/Actual Bonus, prorated bonus, accelerated vesting of time-based equity, and 18 months of COBRA subsidy. In the event of a Change in Control, the severance multiplier increases to three times (or one time in certain circumstances).
Investor Verification Checklist
- Verify the full text of the Employment Agreement filed as Exhibit 10.1 for complete restrictive covenants and performance criteria.
- Confirm the specific performance metrics tied to the Target Annual Bonus and LTIP Units, which are established by the Board.
- Review the Transition and Separation Agreement with Jeffrey M. Busch to understand any remaining financial obligations or non-compete terms.
- Monitor future filings for the impact of the leadership change on the Company's strategic direction and investment pipeline.